Meinian Onehealth Healthcare Holdings (002044) Fair Value & Analysis

Healthcare · CN · Market cap 19.7B CNY

Analysis

Meinian Onehealth Healthcare Holdings (002044) currently trades at ¥5.57, while our model-based Fair Value estimate is ¥2.99 — implying the stock looks roughly 46.3% overvalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Meinian Onehealth Healthcare Holdings Co., Ltd. offers health checkup services. The company integrates health consultation, health assessment, and health management services. It also provides professional prevention, health protection, nutrition and health management consulting, health checkup, medical technology, information technology, health advisory, medical care, and insurance brokerage services. In addition, the company is involved in investment management, physical examination management, software development, and sales. Further, it offers research and experimental development services; sells medicines and medical devices; and engages in financial leasing, factoring, consulting, and pharmaceutical businesses. The company was founded in 1991 and is headquartered in Shanghai, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.